Alba Mendis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alba Mendis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Cindy Luna
La Jolla Institute for Immunology , La Jolla, CA
1 shared publication- Eleni Phung
La Jolla Institute for Immunology
1 shared publication - Gabriel Ascui
La Jolla Institute for Immunology, La Jolla, USA
1 shared publication - Greet Verstichel
La Jolla Institute for Immunology , La Jolla, CA
1 shared publication Hilde Cheroutre
La Jolla Institute for Immunology , La Jolla, CA
1 shared publication- Hsin-Yu Liu
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
1 shared publication
Latest Publications
- 1 February 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (2) , 223-237
Innateness transcriptome gradients characterize mouse T lymphocyte populations
A fundamental dichotomy in lymphocytes separates adaptive T and B lymphocytes, with clonally expressed antigen receptors, from innate lymphocytes, which carry out more rapid responses. Some T cell populations, however, are intermediates between these 2 poles, with the capacity to respond rapidly through T cell receptor activation or by cytokine stimulation. Here, using publicly available datasets, we constructed linear mixed models that not only define a gradient of innate gene expression in common for mouse innate-like T cells, but also are applicable to other mouse T lymphoid populations. A similar gradient could be identified for chromatin landscape based on ATAC-seq (assay for transposase-accessible chromatin using sequencing) data. The gradient included increased transcripts related to many traits of innate immune responses, with increased scores related to evidence for antigen experience. While including genes typical for T helper 1 (Th1) responses, the innateness gene program could be separated from Th1, Th2, and Th17 responses. Lymphocyte populations with higher innateness scores correlated with lower calcium-dependent T cell receptor–mediated cell activation, with some downstream signaling proteins dependent on calcium or affecting metabolism prephosphorylation. Therefore, as a group, different mouse innate-like T cell populations had related gene expression programs and activation pathways that are different from naive CD4 and CD8 T cells.
- 1 February 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (2) , 223-237
Innateness transcriptome gradients characterize mouse T lymphocyte populations
A fundamental dichotomy in lymphocytes separates adaptive T and B lymphocytes, with clonally expressed antigen receptors, from innate lymphocytes, which carry out more rapid responses. Some T cell populations, however, are intermediates between these 2 poles, with the capacity to respond rapidly through T cell receptor activation or by cytokine stimulation. Here, using publicly available datasets, we constructed linear mixed models that not only define a gradient of innate gene expression in common for mouse innate-like T cells, but also are applicable to other mouse T lymphoid populations. A similar gradient could be identified for chromatin landscape based on ATAC-seq (assay for transposase-accessible chromatin using sequencing) data. The gradient included increased transcripts related to many traits of innate immune responses, with increased scores related to evidence for antigen experience. While including genes typical for T helper 1 (Th1) responses, the innateness gene program could be separated from Th1, Th2, and Th17 responses. Lymphocyte populations with higher innateness scores correlated with lower calcium-dependent T cell receptor–mediated cell activation, with some downstream signaling proteins dependent on calcium or affecting metabolism prephosphorylation. Therefore, as a group, different mouse innate-like T cell populations had related gene expression programs and activation pathways that are different from naive CD4 and CD8 T cells.